Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: Azure, a Randomized Trial of Treat-And-Extend Vs. Fixed Dosing

AuthID
 P-00Z-QSC
10
Author(s)
Kodjikian, L
·
Barquet, LA
·
Papp, A
·
Kertes, PJ
·
Midena, E
·
Ernest, J
·
Schmelter, T
·
Niesen, T
·
Document Type
Article in Press
Year published
2024
Published
in ADVANCES IN THERAPY, ISSN: 0741-238X
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 38183525
Scopus: 2-s2.0-85181530426
Wos: WOS:001137206300002
Source Identifiers
ISSN: 0741-238X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service